avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxa2 | mm10_v2_chr2_-_148046896_148046991 | 0.68 | 4.1e-06 | Click! |
Foxa1 | mm10_v2_chr12_-_57546121_57546141 | 0.33 | 5.2e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_113258837 Show fit | 55.12 |
ENSMUST00000098673.3
|
amylase 2a5 |
|
chr3_-_113532288 Show fit | 39.00 |
ENSMUST00000132353.1
|
amylase 2a1 |
|
chr6_+_30541582 Show fit | 28.17 |
ENSMUST00000096066.4
|
carboxypeptidase A2, pancreatic |
|
chr3_-_20275659 Show fit | 27.11 |
ENSMUST00000011607.5
|
carboxypeptidase B1 (tissue) |
|
chr17_-_31144271 Show fit | 25.50 |
ENSMUST00000024826.7
|
trefoil factor 2 (spasmolytic protein 1) |
|
chr2_-_62483637 Show fit | 20.03 |
ENSMUST00000136686.1
ENSMUST00000102733.3 |
glucagon |
|
chr7_+_131032061 Show fit | 17.42 |
ENSMUST00000084509.3
|
deleted in malignant brain tumors 1 |
|
chr6_+_142298419 Show fit | 16.69 |
ENSMUST00000041993.2
|
islet amyloid polypeptide |
|
chr3_+_107230608 Show fit | 13.08 |
ENSMUST00000179399.1
|
RIKEN cDNA A630076J17 gene |
|
chr9_+_46268601 Show fit | 12.35 |
ENSMUST00000121598.1
|
apolipoprotein A-V |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 40.3 | GO:0006508 | proteolysis(GO:0006508) |
3.6 | 25.5 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
2.9 | 20.0 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.9 | 17.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
2.1 | 16.7 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
3.3 | 13.3 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.3 | 9.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 8.4 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.3 | 7.9 | GO:0046688 | response to copper ion(GO:0046688) |
1.2 | 7.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 167.3 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 20.7 | GO:0072562 | blood microparticle(GO:0072562) |
2.5 | 17.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.6 | 13.9 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 13.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
1.1 | 8.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 5.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.2 | 5.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 4.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 4.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.3 | 71.8 | GO:0004556 | alpha-amylase activity(GO:0004556) |
1.7 | 54.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 38.1 | GO:0005179 | hormone activity(GO:0005179) |
1.9 | 24.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 19.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
1.8 | 12.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 11.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.8 | 8.9 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.2 | 7.7 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
2.5 | 7.5 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 30.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 23.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 7.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 6.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 4.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 4.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 3.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 3.0 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 3.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 3.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 19.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.5 | 17.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.5 | 13.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 8.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 8.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
2.6 | 7.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.6 | 7.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 7.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 6.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 5.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |